Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat® soft mist™ inhaler

Delivery of bronchodilators by Respimat® SMI is safe with regard to paradoxical bronchoconstriction during chronic use in patients with asthma or COPD.